FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Boehringer Ingelheim Pharmaceuticals Catapres Recall

Catapres

Boehringer Ingelheim Pharmaceuticals, Inc. · Ridgefield, CT

Risk level
Class II
Reported by FDA
Nov 7, 2018
Recall ID
D-0128-2019
Check your lot numberHow we source this data

Summary

Boehringer Ingelheim Pharmaceuticals recalled Catapres starting Oct 22, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0128-2019 on Nov 7, 2018. Reason: Failed Dissolution Specifications: OOS resultsduring routine stability testing. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: OOS resultsduring routine stability testing

Product description

Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01

Lot numbers, UPCs & expiration codes

Lot: 757739, EXP 9/2020

Where it was sold

Distributed nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0128-2019
Classification
Class II
Status
Terminated
Recall initiated
Oct 22, 2018
FDA report date
Nov 7, 2018
Quantity
1,380 100-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0128-2019, exactly as published.

Show all FDA fields
City
Ridgefield
State
CT
Status
Terminated
Country
United States
Event ID
81340
Address
900 Ridgebury Rd
Code information
Lot: 757739, EXP 9/2020
Postal code
06877-1058
Report date
Nov 7, 2018
Product type
Drugs
Recall number
D-0128-2019
Classification
Class II
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Product quantity
1,380 100-count bottles
Termination date
Apr 3, 2023
Reason for recall
Failed Dissolution Specifications: OOS resultsduring routine stability testing
Voluntary / mandated
Voluntary: Firm initiated
Product description
Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01
Distribution pattern
Distributed nationwide in the USA and Puerto Rico
Recall initiation date
Oct 22, 2018
Initial firm notification
Letter
Center classification date
Nov 1, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0128-2019, published Nov 7, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls